Dyne Therapeutics (DYN) Interest & Investment Income (2019 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Interest & Investment Income of $8.8 million in Q1 2026, up 14.37% quarter-over-quarter from $7.7 million in Q4 2025, and up 23.34% on a YoY basis from $7.1 million in Q1 2025.
Dyne Therapeutics (DYN) Interest & Investment Income (2019 - 2026) Analysis & Trends
Dyne Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 23.34% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $31.5 million (up 1.6% YoY), while the FY2025 annual figure was $29.9 million, up 10.91% from the prior year.
- Interest & Investment Income was $8.8 million for Q1 2026 at Dyne Therapeutics, up from $7.7 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $9.3 million in Q3 2024 to a low of $230000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $4.5 million across 5 years, with a median of $3.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 637.36% in 2022, then decreased 8.62% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $1.3 million in 2022, then soared by 30.48% to $1.8 million in 2023, then surged by 333.58% to $7.6 million in 2024, then increased by 0.86% to $7.7 million in 2025, then increased by 14.37% to $8.8 million in 2026.
- The last three Interest & Investment Income figures came in at $8.8 million (Q1 2026), $7.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - | 8.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.76 Mn |
| Dec 31, 2025 | 7.66 Mn |
| Sep 30, 2025 | 8.48 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Mar 31, 2025 | 7.10 Mn |
| Dec 31, 2024 | 7.59 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 7.05 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 903,000.00 |
| Jun 30, 2022 | 441,000.00 |
| Mar 31, 2022 | 230,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 184,000.00 |
| Jun 30, 2021 | 210,000.00 |